Growth and Margin Analysis of Ikena Oncology Inc (IKNA)’s Recent Quarter Sales

At the time of writing, Ikena Oncology Inc [IKNA] stock is trading at $1.38, up 11.29%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The IKNA shares have gain 6.98% over the last week, with a monthly amount glided 2.99%, and seem to be holding up well over a long-time horizon.

From an analyst’s perspective:

Ikena Oncology Inc [NASDAQ: IKNA] stock has seen the most recent analyst activity on May 29, 2024, when Wedbush downgraded its rating to a Neutral and also revised its price target to $2 from $8. Previously, Wedbush started tracking the stock with Outperform rating on September 22, 2023, and set its price target to $11. H.C. Wainwright started tracking the stock assigning a Buy rating and suggested a price target of $25 on December 23, 2021. In a note dated April 20, 2021, William Blair initiated an Outperform rating.

For the past year, the stock price of Ikena Oncology Inc fluctuated between $0.97 and $1.94. Currently, Wall Street analysts expect the stock to reach $1.33 within the next 12 months. Ikena Oncology Inc [NASDAQ: IKNA] shares were valued at $1.38 at the most recent close of the market. An investor can expect a potential drop of -3.62% based on the average IKNA price forecast.

Analyzing the IKNA fundamentals

To continue investigating profitability, this company’s Return on Assets is posted at -0.32, Equity is -0.32 and Total Capital is -0.42. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.06.

Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.3000 points at the first support level, and at 1.2200 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.4400, and for the 2nd resistance point, it is at 1.5000.

Ratios To Look Out For

It is important to note that Ikena Oncology Inc [NASDAQ:IKNA] has a current ratio of 13.31. In addition, the Quick Ratio stands at 13.31 and the Cash Ratio stands at 4.18.

Related Posts

MZP News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.